Wednesday, July 2, 2025 7/2/2025

Relevance of RPS27L expression quantitative trait locus in pediatric obesity-related asthma

Award Number: R21AI166744
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 11/07/2022
PERIOD OF PERFORMANCE END DATE: 10/31/2024

Group Awards By:

View Award Description

Relevance of RPS27L expression quantitative trait locus in pediatric obesity-related asthma - Obesity-related asthma is the most consistently reported pediatric non-atopic asthma phenotype that is associated with high disease burden and is poorly responsive to asthma medications. It is a major subset of pediatric asthma that is increasing in incidence since 20% of children in the U.S. are overweight/obese, with higher rates observed in Hispanic and African American children. However, not all children who gain weight develop obesity-related asthma, suggesting that genetic susceptibility plays a role. Thus, identification of genetic risk markers for obesity-related asthma will offer opportunities for primary prevention. Investigation of biologic mechanisms underlying the genetic risk will identify novel therapeutic targets for obesity-related asthma, which has no effective treatment options. Our research program is leading the investigation of immunobiology of obesity-related asthma in minority children. In peripheral blood from Hispanic and African American children, we found non-atopic immune responses with T helper (TH)1 cell polarization that correlated with pulmonary function deficits in obesity-related asthma, and was associated with upregulation of Cell Division Cycle 42 (CDC42) pathway in TH cells, which plays an integral role in TH cell migration and differentiation, particularly to TH1 cells; inhibition of CDC42 led to inhibition of TH1 but not TH2 cytokines. Investigation of the contribution of genetic variants to immunobiology of obesity-related asthma in minority children identified a single nucleotide polymorphism (SNP) at rs6494395 locus that functions as an expression quantitative trait locus (eQTL) in TH cells for the gene encoding for ribosomal protein S27 like (RPS27L) protein. The minor allele (C allele), that is 2 to 4 times more prevalent in Hispanic and African populations, was associated with RPS27L downregulation. All three children with C/C genotype were obese with asthma. RPS27L downregulation and homozygosity for C allele were independent predictors of 14% and 10% (respectively) lower FEV1/FVC ratio in obese children with asthma. We therefore speculate that the C allele at the rs6494395 locus is relevant to pediatric obesity-related asthma. Although there is no known links between RPS27L, TH1 cells, CDC42, or asthma, RPS27L is a target and a modulator of p53, which plays a key role in control of TH cell proliferation and modulates CDC42 to control cell migration. These findings form the premise for this proposal. We hypothesize that C allele at rs6494395 locus is a novel at-risk allele that confers susceptibility to non-atopic obesity-related asthma in minority children by downregulating RPS27L which downregulates p53 activity in TH cells, causing increased TH1 cell proliferation and CDC42-mediated cell migration. To test our hypothesis, we will investigate 1) the ancestry of C allele at rs6494395, and its links with RPS27L expression, TH1 polarization, and disease burden in obese children with asthma, relative to obese children without asthma, and healthy-weight children with and without asthma, and 2) novel mechanistic links between RPS27L, p53, and CDC42 in healthy TH1 cells and the presence of these links in TH1 cells from obese children with asthma.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$2,771 )
2025	2023	CHILDREN'S RESEARCH INSTITUTE	111 MICHIGAN AVE NW	WASHINGTON	DC	20010	DISTRICT OF COLUMBIA	USA	Allergy and Infectious Diseases Research	000	1	1/13/2025	NEW	-$2,771
														Subtotal = -$2,771

Issue Date FY: 2024 ( Subtotal = $210,000 )
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Allergy and Infectious Diseases Research	000	3	10/31/2023	NON-COMPETING CONTINUATION	$189,001
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Allergy and Infectious Diseases Research	001	3	5/14/2024	NON-COMPETING CONTINUATION	$20,999
2024	2023	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Allergy and Infectious Diseases Research	003	2	5/14/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$20,001
2024	2023	CHILDREN'S RESEARCH INSTITUTE	111 MICHIGAN AVE NW	WASHINGTON	DC	20010	DISTRICT OF COLUMBIA	USA	Allergy and Infectious Diseases Research	002	1	5/14/2024	NEW	-$20,001
														Subtotal = $210,000

Issue Date FY: 2023 ( Subtotal = $282,742 )
2023	2023	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Allergy and Infectious Diseases Research	005	2	7/24/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$78,401
2023	2023	CHILDREN'S RESEARCH INSTITUTE	111 MICHIGAN AVE NW	WASHINGTON	DC	20010	DISTRICT OF COLUMBIA	USA	Allergy and Infectious Diseases Research	002	1	5/31/2023	NEW	-$252,000
2023	2023	CHILDREN'S RESEARCH INSTITUTE	111 MICHIGAN AVE NW	WASHINGTON	DC	20010	DISTRICT OF COLUMBIA	USA	Allergy and Infectious Diseases Research	004	1	7/24/2023	NEW	$78,401
2023	2023	CHILDREN'S RESEARCH INSTITUTE	111 MICHIGAN AVE NW	WASHINGTON	DC	20010	DISTRICT OF COLUMBIA	USA	Allergy and Infectious Diseases Research	001	1	11/21/2022	NEW	$5,437
2023	2023	CHILDREN'S RESEARCH INSTITUTE	111 MICHIGAN AVE NW	WASHINGTON	DC	20010	DISTRICT OF COLUMBIA	USA	Allergy and Infectious Diseases Research	000	1	11/7/2022	NEW	$277,305
2023	2023	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Allergy and Infectious Diseases Research	003	2	6/1/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$252,000
														Subtotal = $282,742

Grand Total All Awards = $489,971

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Relevance of RPS27L expression quantitative trait locus in pediatric obesity-related asthma

Award Number: R21AI166744

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 11/07/2022

PERIOD OF PERFORMANCE END DATE: 10/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer